Medartis Holding AG
SIX:MED

Watchlist Manager
Medartis Holding AG Logo
Medartis Holding AG
SIX:MED
Watchlist
Price: 81.3 CHF -0.37% Market Closed
Market Cap: CHf1.1B

Medartis Holding AG
EPS (Diluted)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Medartis Holding AG
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Medartis Holding AG
SIX:MED
EPS (Diluted)
CHf0
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Alcon AG
SIX:ALC
EPS (Diluted)
$1
CAGR 3-Years
43%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Coltene Holding AG
SIX:CLTN
EPS (Diluted)
CHf2
CAGR 3-Years
-17%
CAGR 5-Years
13%
CAGR 10-Years
N/A
Ypsomed Holding AG
SIX:YPSN
EPS (Diluted)
CHf14
CAGR 3-Years
82%
CAGR 5-Years
75%
CAGR 10-Years
22%
IVF Hartmann Holding AG
SIX:VBSN
EPS (Diluted)
CHf7
CAGR 3-Years
18%
CAGR 5-Years
1%
CAGR 10-Years
1%
No Stocks Found

Medartis Holding AG
Glance View

Market Cap
1.1B CHF
Industry
Health Care

Medartis Holding AG operates as a medical device company. The company is headquartered in Basel, Basel-Stadt and currently employs 684 full-time employees. The company went IPO on 2018-03-23. The Group develops, manufactures and distributes to surgeons, hospitals and medical centers titanium screws, plates, surgical instruments and system solutions for internal fracture fixation. Medartis AG, the Company's wholly-owned subsidiary, has developed such technologies as TriLock for locking the screw into the plate, SpeedTip, a screw that does not require pre-drilling, and HexaDrive self-holding screw and screw-driver. The company has two product lines. The APTUS product line comprises upper and lower extremities products for hand, wrist, elbow, shoulder and foot fixation. The MODUS line combines products dedicated to cranio-maxillofacial (CMF) surgery. The Group's products are sold globally in more than 30 countries, including Germany and the United States, either directly through its sales subsidiaries, or through third-party distributors.

MED Intrinsic Value
72.44 CHF
Overvaluation 11%
Intrinsic Value
Price CHf81.3

See Also

What is Medartis Holding AG's EPS (Diluted)?
EPS (Diluted)
0.7 CHF

Based on the financial report for Dec 31, 2025, Medartis Holding AG's EPS (Diluted) amounts to 0.7 CHF.

What is Medartis Holding AG's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 1Y
131%

Over the last year, the EPS (Diluted) growth was 131%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett